Corti Marcelo, Minué Gonzalo, Campitelli Ana, Narbaitz Marina, Gilardi Leonardo
Department of HIV/AIDS, Infectious Diseases F. J. Muñiz Hospital, Buenos Aires, Argentina ; Department of Internal Medicine, University of Buenos Aires School of Medicine, Paraguay, Buenos Aires, Argentina.
Department of Hematology Unit, Infectious Diseases F. J. Muñiz Hospital, Buenos Aires, Argentina.
Int Arch Otorhinolaryngol. 2015 Oct;19(4):354-8. doi: 10.1055/s-0034-1397335. Epub 2015 Jan 8.
Introduction Plasmablastic lymphoma is a rare entity that was first described in the jaws and the oral cavity of patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Plasmablastic lymphoma is considered as a diffuse, large, B-cell lymphoma with a unique phenotype and a predilection for the oral cavity. Objective The authors describe a case of an aggressive plasmablastic lymphoma of the oral cavity as the primary manifestation of AIDS. Resumed Report We report a case of plasmablastic lymphoma involving only the oral cavity as the first manifestation of AIDS. Diagnosis was confirmed by the oral lesion biopsy and the histopathologic examination that showed a dense infiltrate composed of atypical lymphocytes with numerous plasmocytes that expressed the plasma cell markers MUM-1 and CD138 and that were negative for the B-cell markers CD3, CD20, and CD45. Immunohistochemical and in situ hybridization revealed the Epstein-Barr virus genome in the atypical cells. Polymerase chain reaction was also positive for human herpesvirus-8 RNA. Conclusion The HIV serologic status should be evaluated in all patients with plasmablastic lymphoma of the oral cavity or extraoral sites.
引言 浆母细胞性淋巴瘤是一种罕见的疾病,最初在人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合征(AIDS)患者的颌骨和口腔中被描述。浆母细胞性淋巴瘤被认为是一种具有独特表型且好发于口腔的弥漫性大B细胞淋巴瘤。目的 作者描述了一例侵袭性口腔浆母细胞性淋巴瘤作为艾滋病的主要表现。病例报告 我们报告一例仅累及口腔的浆母细胞性淋巴瘤作为艾滋病的首发表现。通过口腔病变活检和组织病理学检查确诊,结果显示由非典型淋巴细胞和大量浆细胞组成的致密浸润,这些浆细胞表达浆细胞标志物MUM-1和CD138,而B细胞标志物CD3、CD20和CD45为阴性。免疫组织化学和原位杂交显示非典型细胞中存在EB病毒基因组。聚合酶链反应检测人疱疹病毒8型RNA也呈阳性。结论 对于所有患有口腔或口腔外浆母细胞性淋巴瘤的患者,均应评估其HIV血清学状态。